First-line (1L) datopotamab deruxtecan (Dato-DXd) plus rilvegostomig in advanced or metastatic non-small cell lung cancer (a/mNSCLC): Results from TROPION-Lung04 (cohort 5).


Por: Waqar, SN, Cuppens, K, Campelo, RG, Dziadziuszko, R, Carcereny, E, Yang, TY, Shih, JY, Dutcher, G, Novello, S, Chmielewska, I, Kalinka, E, Sendur, MAN, Wakuda, K, Tyulyandina, A, Hinzmann, M, Shi, XJ, Bodla, S and Papadopoulos, KP

Publicada: 1 jun 2025
Resumen:


Filiaciones:
Washington Univ, Sch Med St Louis, St Louis, MO USA
Jessa Hosp, Hasselt, Belgium
UHasselt, Fac Med & Life Sci LCRC, Diepenbeek, Belgium
Univ Hosp A Coruna HRS4R Universia Gal, La Coruna, Spain
Med Univ Gdansk, Gdansk, Poland
Hosp Badalona Germans Trias & Pujol, Barcelona, Spain
Taichung Vet Gen Hosp, Chest Med, Taichung, Taiwan
Natl Taiwan Univ Hosp, Dept Internal Med, Taipei City, Taiwan
Univ Hosp Seidman Canc Ctr, Internal Med & Oncol, Cleveland, OH USA
AOU San Luigi, Dept Oncol, Turin, Italy
Med Univ Lublin, Dept Pneumonol Oncol & Allergol, Lublin, Poland
Inst Ctr Zdrow Matki Polki, Dept Oncol, Lodz, Poland
Ankara Yildirim Beyazit Univ, Istanbul, Turkiye
Ankara Bilkent City Hosp, Istanbul, Turkiye
Shizuoka Canc Ctr, Dept Thorac Dis, Shizuoka, Japan
AstraZeneca, Barcelona, Spain
AstraZeneca, R&D, Warsaw, Poland
AstraZeneca, R&D, Gaithersburg, MD USA
AstraZeneca, Cambridge, England
South Texas Accelerated Res Therapeut START, Clin Res Dept, San Antonio, TX USA
ISSN: 0732183X





JOURNAL OF CLINICAL ONCOLOGY
Editorial
American Society of Clinical Oncology, 2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA, Estados Unidos America
Tipo de documento: Meeting Abstract
Volumen: 43 Número: 16_SUPPL
Páginas:
WOS Id: 001690322200047

MÉTRICAS